CanZx Biotherapeutics

CanZx Biotherapeutics Overview

Founded 2015
Status Private
Employees 4
Latest Deal Type Grant
Latest Deal Amount $50K
Latest Deal Amount
Investors 2

CanZx Biotherapeutics General Information


Developer of a cancer antibody designed to empower the immune system to fight cancer. The company's immunotherapeutic antibody boosts the immune system to fight cancer and also enhances response of tumors which are non-responsive to immunotherapies, enabling patients to improve their ability to fight cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Primary Office
  • 1531 North East 172nd Street
  • Shoreline, WA 98155
  • United States
+1 (206) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CanZx Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 18-Jan-2017 $50K Completed Startup
1. Grant 01-Jan-2016 00000 Completed Startup

CanZx Biotherapeutics Executive Team (1)

Name Title Board Seat Contact Info
Jennifer Wu Ph.D Founder & President

CanZx Biotherapeutics Investors (2)

To view CanZx Biotherapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SC Launch Not-For-Profit Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Ready to get started?

Request a free trial